Unravel the intricacies of Cell Line Development in biotherapeutics production with our latest eBook chapter.
Biologic drugs are revolutionizing medicine, offering promising alternatives to traditional, small-molecule therapeutic modalities. However, the production process for many biologics, particularly antibodies and recombinant proteins, presents significant challenges across development. Cell line development is a challenging step in antibody CMC. This eBook chapter delves into these challenges, focusing on stable transfections required during CLD. It discusses:
Offered Free by: Danaher Life Sciences
See All Resources from: Danaher Life Sciences